Clinical trials
Phase 1 Lymphoma trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Terminated | 6 |
| Recruiting | 5 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BeiGene | 2 |
| Celgene | 2 |
| Novartis Pharmaceuticals | 2 |
| Alpine Immune Sciences, Inc. | 1 |
| Antengene Biologics Limited | 1 |
| Arovella Therapeutics Ltd | 1 |
| CRISPR Therapeutics AG | 1 |
| Caribou Biosciences, Inc. | 1 |
| Cellectar Biosciences, Inc. | 1 |
| EpimAb Biotherapeutics (Suzhou)Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 24 |
| Lymphoma, Non-Hodgkin | 8 |
| Leukemia | 6 |
| Recurrence | 6 |
| Multiple Myeloma | 4 |
| Lymphoma, B-Cell | 3 |
| Melanoma | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma, Follicular | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.